666
Views
27
CrossRef citations to date
0
Altmetric
Letters to the Editor

Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

ORCID Icon, , , &
Pages 1973-1976 | Received 04 Oct 2016, Accepted 27 Nov 2016, Published online: 14 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Christopher Pleyer, Adrian Wiestner & Clare Sun. (2018) Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia. Leukemia & Lymphoma 59:12, pages 2792-2800.
Read now
Francesca R. Mauro, Maria D. Caputo, Serena Rosati, Sara Pepe, Daniela De Benedittis, Maria L De Luca & Robin Foà. (2018) Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:8, pages 601-611.
Read now
Abdallah Abou Zahr, Prithviraj Bose & Michael J. Keating. (2017) Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 18:9, pages 857-873.
Read now

Articles from other publishers (24)

Isla M. Johnson, Caleb Scheckel, Sameer A. Parikh, Mark Enzler, Jennifer Fugate & Timothy G. Call. (2022) Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia. Blood Cancer Journal 12:10.
Crossref
Lauren J. Fried, Maressa C. Criscito, Mary L. Stevenson & Miriam K. Pomeranz. (2021) Chronic lymphocytic leukemia and the skin: implications for the dermatologist. International Journal of Dermatology 61:5, pages 519-531.
Crossref
Yandong Shen, Jane A. Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, Paul Downe, Catherine Tang, Ian Kerridge, Lucinda Wallman, Nenna Van Bilsen, Vanessa Milogiannakis, Anouschka Akerman, Gabriela Martins Costa Gomes, Kerrie Sandgren, Anthony L. Cunningham, Stuart Turville & Stephen P. Mulligan. (2022) COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity. British Journal of Haematology 197:1, pages 41-51.
Crossref
Larissa Henze, Christoph Buhl, Michael Sandherr, Oliver A. Cornely, Werner J. Heinz, Yascha Khodamoradi, Til Ramon Kiderlen, Philipp Koehler, Alrun Seidler, Rosanne Sprute, Martin Schmidt-Hieber & Marie von Lilienfeld-Toal. (2022) Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Annals of Hematology 101:3, pages 491-511.
Crossref
Eli Muchtar, Amber B. Koehler, Michael J. Johnson, Kari G. Rabe, Wei Ding, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Suzanne R. Hayman, Yucai Wang, Paul J. Hampel, Matthew A. Holets, Heather C. Darby, Susan L. Slager, Neil E. Kay, Congrong Miao, Jennifer Canniff, Jennifer A. Whitaker, Myron J. Levin, D. Scott Schmid, Richard B. Kennedy, Adriana Weinberg & Sameer A. Parikh. (2021) Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. American Journal of Hematology 97:1, pages 90-98.
Crossref
Maria Stefania Infante, Ana Fernández‐Cruz, Lucia Núñez, Cecilia Carpio, Ana Jiménez‐Ubieto, Javier López‐Jiménez, Lourdes Vásquez, Raquel Del Campo, Samuel Romero, Carmen Alonso, Daniel Morillo, Margarita Prat, José Luis Plana, Paola Villafuerte, Gabriela Bastidas, Ana Bocanegra, Ángel Serna, Rodrigo De Nicolás, Juan Marquet, Carmen Mas‐Ochoa, Raúl Cordoba, Julio García‐Suárez, Alessandra Comai, Xavier Martín, Mariana Bastos‐Oreiro, Cristina Seri, Belén Navarro‐Matilla, Armando López‐Guillermo, Joaquín Martínez‐López, José Ángel Hernández‐Rivas, Isabel Ruiz‐Camps & Carlos Grande. (2021) Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study. Cancer Medicine 10:21, pages 7629-7640.
Crossref
Francesca Romana Mauro, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Claudia Ielo, Alessandro Noto, Valerio Guarente, Stefano Molica, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foà, Maurizio Martelli, Corrado Girmenia, Giuseppe Gentile & Livio Trentin. (2021) Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Cancers 13:13, pages 3240.
Crossref
Vilhjálmur Steingrímsson, Gauti Kjartan Gíslason, Sigrún Þorsteinsdóttir, Sæmundur Rögnvaldsson, Magnús Gottfreðsson, Thor Aspelund, Ingemar Turesson, Magnus Björkholm, Ola Landgren & Sigurdur Y. Kristinsson. (2020) A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre‐ibrutinib era. European Journal of Haematology 106:3, pages 346-353.
Crossref
Akihiro Ohmoto & Shigeo Fuji. (2021) Infection profiles of different chemotherapy regimens and the clinical feasibility of antimicrobial prophylaxis in patients with DLBCL. Blood Reviews 46, pages 100738.
Crossref
Alessandro Busca, Chiara Cattaneo, Elena De Carolis, Gianpaolo Nadali, Massimo Offidani, Marco Picardi, Anna Candoni, Eleonora Ceresoli, Marianna Criscuolo, Mario Delia, Roberta Della Pepa, Ilaria Del Principe, Roma. Rosa Fanci, Francesca Farina, Nicola Fracchiolla, Claudia Giordano, Michele Malagola, Francesco Marchesi, Monica Piedimonte, Lucia Prezioso, Angela Maria Quinto, Angelica Spolzino, Maria Chiara Tisi, Fabio Trastulli, Enrico Maria Trecarichi, Patrizia Zappasodi, Mario Tumbarello & Livio Pagano. (2021) Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper. Critical Reviews in Oncology/Hematology 158, pages 103203.
Crossref
Hamdi Akan, Tony Bruns & Mathias W. Pletz. 2021. Infection Management in Hematology. Infection Management in Hematology 57 75 .
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye & Michael Boyle. (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 33:3.
Crossref
Masa Lasica & Constantine S. Tam. (2020) Management of Ibrutinib Toxicities: a Practical Guide. Current Hematologic Malignancy Reports 15:3, pages 177-186.
Crossref
Barbara Rogers. (2020) B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management. Clinical Journal of Oncology Nursing 24:2, pages 199-204.
Crossref
Inuk Zandvakili, James W. Lloyd & Karthik V. Giridhar. (2019) Hepatitis, Pancreatitis and Rash in a Patient With Chronic Lymphocytic Leukemia. Gastroenterology 157:4, pages e8-e9.
Crossref
Clive S. Zent. (2019) Diagnosis and management of complications of chronic lymphocytic leukemia/small lymphocytic lymphoma. Acta Haematologica Polonica 50:3, pages 91-97.
Crossref
Christopher P Eades & Darius P H Armstrong-James. (2019) Invasive fungal infections in the immunocompromised host: Mechanistic insights in an era of changing immunotherapeutics. Medical Mycology 57:Supplement_3, pages S307-S317.
Crossref
Pier Luigi Zinzani, Alessandro Rambaldi, Gianluca Gaidano, Corrado Girmenia, Monia Marchetti, Fabrizio Pane, Sante Tura & Giovanni Barosi. (2019) Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. Leukemia Research 81, pages 88-94.
Crossref
Benjamin W. Teh, Constantine S. Tam, Sasanka Handunnetti, Leon J. Worth & Monica A. Slavin. (2018) Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies. Blood Reviews 32:6, pages 499-507.
Crossref
Sameer A. Parikh. (2018) Chronic lymphocytic leukemia treatment algorithm 2018. Blood Cancer Journal 8:10.
Crossref
Talal Hilal, Juan C. Gea-Banacloche & Jose F. Leis. (2018) Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections. Blood Reviews 32:5, pages 387-399.
Crossref
Jennifer R. Brown. (2018) How I treat CLL patients with ibrutinib. Blood 131:4, pages 379-386.
Crossref
Jennifer R. Brown & Neil E. Kay. (2017) Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 35:26, pages 2989-2992.
Crossref
. (2017) Ibrutinib/idelalisib. Reactions Weekly 1656:1, pages 250-250.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.